Works by HEIKKIL, H.


Results: 3
    1
    2
    3

    A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet<sup>®</sup>/Daivobet<sup>®</sup>/Taclonex<sup>®</sup>) in the treatment of psoriasis vulgaris.

    Published in:
    British Journal of Dermatology, 2006, v. 154, n. 6, p. 1155, doi. 10.1111/j.1365-2133.2006.07236.x
    By:
    • Kragballe, K.;
    • Austad, J.;
    • Barnes, L.;
    • Bibby, A.;
    • de la Brassinne, M.;
    • Cambazard, F.;
    • Fleming, C.;
    • Heikkil, H.;
    • Jolliffe, D.;
    • Peyri, J.;
    • Svensson, Å.;
    • Toole, J.;
    • Wozel, G.
    Publication type:
    Article